
Cipla Limited has informed the Exchange regarding a press release dated Jun 29, 2021, titled "Cipla, Dr. Reddy s, Emcure, Sun Pharma and Torrent to collaborate for clinical trial of investigational anti-viral drug Molnupiravir for COVID-19 ".
Filed with NSE · · 4 pages · English
This initiative marks a significant first within the Indian pharmaceutical industry, as the companies will jointly sponsor and monitor the trial. The trial is expected to take place over several months, following approval from regulatory authorities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries

Cipla Limited has informed the Exchange regarding a press release dated Jun 29, 2021, titled "Cipla, Dr. Reddy s, Emcure, Sun Pharma and Torrent to collaborate for clinical trial of investigational anti-viral drug Molnupiravir for COVID-19 ".
Follow Cipla into a list and get an email when it puts out news.
Follow Cipla